Skip to content

Protein supplementation to augment the training adaptations to endurance-type exercise training.

Protein supplementation to augment the training adaptations to endurance-type exercise training. - Protein and endurance exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45348
Enrollment
60
Registered
2017-05-23
Start date
2017-05-14
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inspanningscapaciteit muscle function oxidative capacity

Interventions

Exercise training: During the 12-week exercise training program participants will complete three exercise sessions weekly. In the training programs continuous endurance exercise sessions will be alt

Sponsors

Hogeschool van Arnhem en Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male Age between 18 and 40 years of age BMI between 18 * 30 kg/m2 Untrained or recreationally active (i.e. performing sports on a non-competitive basis for a maximal duration of 6 hours per week). VO2max *50 ml/kg/min Willing to give blood samples Able to be present at required test days Able to perform three exercise sessions weekly for 12 weeks

Exclusion criteria

Exclusion criteria: Blood donation during the study period Lactose intolerance and/or dairy protein allergy Consumption of >21 alcoholic beverages per week Use of illicit drugs Use of antibiotics in the past month Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, rheumatoid arthritis, orthopedic disorders, renal disease, liver disease, diabetes mellitus, inflammatory disease, cognitive impairment) Use of medications known to interfere with selected outcome measures (i.e. statins, fenofibrate, beta-blocker, corticosteroids) (Chronic) injuries of the locomotor system that can interfere with the intervention Current participation in other biomedical research study.

Design outcomes

Primary

MeasureTime frame
Maximal oxygen uptake (VO2max): VO2max will be assessed by indirect calorimetry during an incremental exercise prototocol on a cycling ergometer (indirect calorimetry).

Secondary

MeasureTime frame
Exercise performance: Exercise performance will be assessed by a 10 km time trial. Muscle function: Maximal strength and muscular endurance will be assessed by isokinetic dynamometry. Body composition: Whole body and regional body composition will be assessed by a DXA scan and by skinfold measurements according to ISAK standards (International Society for the Advancement of Kinanthropometry). Hematological and biochemical variables (blood): complete blood count, ferritin, CRP, and markers of bone and joint health. Mitochondrial function: Mitochondrial function will be assessed in peripheral blood mononuclear cells (PBMCs)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)